Clinical and biochemical effects of the selective phosphodiesterase inhibitor rolipram in depressed inpatients controlled by determination of plasma level.
Laux
G
G
Department of Psychiatry, University of Wuerzburg, FRG.
Becker
T
T
Kühne
G
G
Lesch
K P
KP
Riederer
P
P
Beckmann
H
H
D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D015306:Biogenic Monoamines / Q000652:urine; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011760:Pyrrolidinones / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D020889:Rolipram
D000928:Antidepressive Agents; D015306:Biogenic Monoamines; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D020889:Rolipram